Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,958 total articles

Village Farms Announces $15 Million Registered Direct Equity Investment from Leading U.S. Institutional Investors

Village Farms Announces $15 Million Registered Direct Equity Investment from Leading U.S. Institutional Investors

Village Farms International announced a registered direct offering raising $15 million from prominent U.S. institutional investors, enhancing its liquidity position following a strong cash balance at the end of Q1 2026. The investment reflects confidence in Village Farms’ leadership in the cannabis and plant-based consumer goods sectors across Nort…

Hurco Reports Second Quarter Results for Fiscal Year 2026

Hurco Reports Second Quarter Results for Fiscal Year 2026

Hurco Companies, Inc. announced fiscal Q2 2026 results, showing a significant reduction in net losses compared to the prior year despite continuing losses. Sales and order intake rose strongly by 17% and 41% respectively year-over-year, driven by increased demand for their 5-axis and high-performance vertical milling machines globally, especially i…

CareCloud Shareholders Overwhelmingly Approve All Proposals, Reaffirming Confidence in Company Leadership and Strategy

CareCloud Shareholders Overwhelmingly Approve All Proposals, Reaffirming Confidence in Company Leadership and Strategy

CareCloud, Inc. announced that its shareholders unanimously approved key proposals at the 2026 Annual Shareholders' Meeting. These approvals included the re-election of board members Mahmud Haq and Cameron Munter, executive compensation plans, the 2026 Equity Incentive Plan, and the appointment of Tanner LLP as the independent auditor. The strong s…

Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease

Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease

Amneal Pharmaceuticals announced positive interim results from its Phase 4 ELEVATE-PD study evaluating CREXONT®, an extended-release carbidopa/levodopa therapy for Parkinson's disease. The study of 214 patients showed significant increases in daily "Good On" time, reductions in "Off" time, and improved motor function, reinforcing prior Phase 3 find…

Sinclair Re-Elects Board, Ratifies and Approves Other Proposals

Sinclair Re-Elects Board, Ratifies and Approves Other Proposals

Sinclair, Inc., a major diversified media company, announced the election of its nine nominated directors during its Annual Stockholders' Meeting. Additionally, stockholders ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026 and approved a non-binding advisory vote on executive compensation…

LGI Homes Celebrates National Homeownership Month

LGI Homes Celebrates National Homeownership Month

LGI Homes, Inc. recognizes National Homeownership Month, emphasizing its dedication to helping over 80,000 families achieve homeownership through its brands LGI Homes and Terrata Homes. The company highlights its commitment to quality construction, customer service, and supporting homebuyers at all stages across 36 markets in 21 states.

Abercrombie & Fitch Expands Retail Presence in SoHo

Abercrombie & Fitch Expands Retail Presence in SoHo

Abercrombie & Fitch Co. announced the opening of its new flagship store in SoHo, New York City, featuring a three-floor layout with expanded product lines including men’s and women’s apparel, accessories, and exclusive merchandise. The store highlights the brand’s 134-year heritage combined with modern design, reinforcing its position as an elevate…

Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar

Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar

Clearmind Medicine Inc., a clinical-stage biotech company specializing in non-hallucinogenic neuroplastogen-derived therapeutics, will host a live webinar on June 10, 2026 to discuss new clinical data from its ongoing FDA-approved Phase I/IIa trial of CMND-100, a MEAI-based oral drug candidate for Alcohol Use Disorder treatment. The webinar feature…

Climb Bio Presents CLYM116 Initial Phase 1 Safety Data and Translational Modeling Results at European Renal Association (ERA) Congress 2026 Supporting Continued Development

Climb Bio Presents CLYM116 Initial Phase 1 Safety Data and Translational Modeling Results at European Renal Association (ERA) Congress 2026 Supporting Continued Development

Climb Bio announced promising initial Phase 1 safety and pharmacometric modeling data for CLYM116, its anti-APRIL monoclonal antibody targeting IgA nephropathy (IgAN). The favorable safety profile in healthy volunteers supports continued clinical development. The company plans further data presentations and expects dosing initiation in IgAN patient…

Portillo’s Comes Home to the Heart of Chicago with Plans to Open Landmark Michigan Avenue Restaurant

Portillo’s Comes Home to the Heart of Chicago with Plans to Open Landmark Michigan Avenue Restaurant

Portillo's, a Chicago-born fast-casual restaurant chain known for Italian beef sandwiches and Chicago-style hot dogs, is opening a new flagship restaurant on Michigan Avenue, marking its first inline location in Chicago and continuing its expansion. This location emphasizes the brand's connection to its roots and reflects a broader growth strategy …

Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027

Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027

Seres Therapeutics announced two financial transactions: a $25 million milestone buy-out agreement with Nestlé Health Science for their former VOWST business, and a restructured lease agreement reducing ongoing costs. These moves improve Seres' balance sheet, lower facility expenses, and extend their operating cash runway well into the first quarte…

SEALSQ Establishes Pure Play Quantum Platform Through Strategic Acquisitions and Investments Across Leading Quantum Computing Companies

SEALSQ Establishes Pure Play Quantum Platform Through Strategic Acquisitions and Investments Across Leading Quantum Computing Companies

SEALSQ Corp is advancing its position in quantum technology by acquiring interests in multiple leading quantum computing firms across diverse qubit technologies. This strategic expansion, termed the "Root-to-Qubit" stack, integrates its established post-quantum cryptography semiconductor business with emerging quantum hardware, aiming to create a v…

Bimergen Energy (BESS) to Present Path to $400 Million Revenues in The Small Cap Showcase & Water Tower Research Insights, June 9, 2026

Bimergen Energy (BESS) to Present Path to $400 Million Revenues in The Small Cap Showcase & Water Tower Research Insights, June 9, 2026

Bimergen Energy Corporation (NYSE American: BESS) announced that Co-CEO Bob Brilon will present at The Small Cap Showcase & WTR Insights in New York City on June 9, 2026. The company is leveraging its recent uplisting to NYSE American and is focusing on funding revenue growth via project-specific financing while monetizing its existing energy stora…